Provision of hepatitis C education in a nationwide sample of drug treatment programs

Janetta Astone, Shiela M. Strauss, Zdravko P. Vassilev, Don C. Des Jarlais

Research output: Contribution to journalArticle

Abstract

Hepatitis C virus (HCV) has reached epidemic proportions among drug users, and drug programs are in a unique position to provide each of their patients with HCV education. Using a nationwide sample (N= 434) of drug treatment programs, we report the results of a logistic regression analysis that differentiates programs providing HCV education to all of their patients versus programs that do not. Fifty-four percent of the programs provide HCV education to all of their patients. Programs are about four and a half times as likely to provide HCV education to all patients if they dispense methadone; almost four times as likely to provide this service if they educate most of their staff about HCV; twice as likely if they are residential; and almost twice as likely if they conduct HIV testing on-site. Our findings indicate that there is a need to increase HCV educational services in drug treatment programs.

Original languageEnglish (US)
Pages (from-to)107-117
Number of pages11
JournalJournal of drug education
Volume33
Issue number1
DOIs
StatePublished - 2003

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Health(social science)
  • Public Health, Environmental and Occupational Health
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Provision of hepatitis C education in a nationwide sample of drug treatment programs'. Together they form a unique fingerprint.

  • Cite this